VISCHER advised Kuros Biosciences

Kuros Biosciences completes a rights offering and share placement in which a total of 10,341,432 new registered shares of Kuros sourced from the ordinary and authorized share capital with a nominal value of CHF 1.00 each were offered or placed, respectively, at an offer price of CHF 1.80 per share. Total gross proceeds raised from the capital increase amount to CHF 18.6m. Kuros intends to use the proceeds of the offering to accelerate and advance the commercial roll-out of its product MagnetOs and to advance the further clinical development of its product candidate Fibrin-PTH.

The team

VISCHER advised Kuros Biosciences with Matthias Staehelin (Partner, Corporate – pictured), Sebastian Flückiger (Associate, Corporate), Nadia Tarolli (Partner, Tax) and Adrian Briner (Senior Associate, Tax).

As previosuly reported by, Bär & Karrer acted as legal adviser to Octavian and Helvetische Bank in this transaction. The team included Thomas U. ReutterAlexander von Jeinsen and Carlo Hunter (all Capital Markets) as well as Christoph Suter and David Weimann (both Tax).

VISCHER advised Kuros Biosciences


Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram